Literature DB >> 19961850

Neurodegeneration in autoimmune CNS inflammation.

Josephine Herz1, Frauke Zipp, Volker Siffrin.   

Abstract

Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system, in which the myelin sheath has been considered to be the primary target for many years. However, an increasing number of reports have focused on neurodegenerative aspects of the disease pathogenesis. Recent studies in post-mortem MS biopsies and in the animal model Experimental Autoimmune Encephalomyelitis (EAE) have shown that key features of neurodegeneration, i.e. axonal transection, neuronal cell atrophy and neuronal death already occur in early disease phases. Furthermore, it has become clear that irreversible disability correlates stronger with the neuronal affectation than with demyelination. However the cause of neuronal damage still remains elusive, since both demyelination-dependent and direct immune cell-mediated mechanisms have been suggested so far. Here, we summarize the current concepts and recently identified molecular mechanisms of inflammatory neurodegeneration in autoimmune CNS inflammation and highlight the role of different immune cells in the complex network of interactions leading to neuronal damage. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19961850     DOI: 10.1016/j.expneurol.2009.11.019

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  39 in total

1.  Effect of Bushen Yisui Capsule () on oligodendrocyte lineage genes 1 and 2 in mice with experimental autoimmune encephalomyelitis.

Authors:  Tao Yang; Qi Zheng; Hui Zhao; Qiu-Xia Zhang; Ming Li; Fang Qi; Kang-Ning Li; Ling Fang; Lei Wang; Yong-Ping Fan
Journal:  Chin J Integr Med       Date:  2016-02-26       Impact factor: 1.978

2.  Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis.

Authors:  Brittany L Hartwell; Chad J Pickens; Martin Leon; Cory Berkland
Journal:  Biomacromolecules       Date:  2017-05-17       Impact factor: 6.988

Review 3.  Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration.

Authors:  Rory D Spence; Rhonda R Voskuhl
Journal:  Front Neuroendocrinol       Date:  2011-12-24       Impact factor: 8.606

4.  Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Authors:  Natalia Gonzalez Caldito; Shiv Saidha; Elias S Sotirchos; Blake E Dewey; Norah J Cowley; Jeffrey Glaister; Kathryn C Fitzgerald; Omar Al-Louzi; James Nguyen; Alissa Rothman; Esther Ogbuokiri; Nicholas Fioravante; Sydney Feldman; Ohemaa Kwakyi; Hunter Risher; Dorlan Kimbrough; Teresa C Frohman; Elliot Frohman; Laura Balcer; Ciprian Crainiceanu; Peter C M Van Zijl; Ellen M Mowry; Daniel S Reich; Jiwon Oh; Dzung L Pham; Jerry Prince; Peter A Calabresi
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

5.  Response to oxidative stress of peripheral blood mononuclear cells from multiple sclerosis patients and healthy controls.

Authors:  Cristiana Pistono; Maria Cristina Monti; Chiara Boiocchi; Francesca Gigli Berzolari; Cecilia Osera; Giulia Mallucci; Mariaclara Cuccia; Alessia Pascale; Cristina Montomoli; Roberto Bergamaschi
Journal:  Cell Stress Chaperones       Date:  2019-11-12       Impact factor: 3.667

Review 6.  Will the real multiple sclerosis please stand up?

Authors:  Peter K Stys; Gerald W Zamponi; Jan van Minnen; Jeroen J G Geurts
Journal:  Nat Rev Neurosci       Date:  2012-06-20       Impact factor: 34.870

7.  Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis.

Authors:  Wensheng Lin; Yifeng Lin; Jin Li; Ali G Fenstermaker; Sharon W Way; Benjamin Clayton; Stephanie Jamison; Heather P Harding; David Ron; Brian Popko
Journal:  J Neurosci       Date:  2013-04-03       Impact factor: 6.167

8.  PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases.

Authors:  Yifeng Lin; Guangcun Huang; Stephanie Jamison; Jin Li; Heather P Harding; David Ron; Wensheng Lin
Journal:  Am J Pathol       Date:  2013-11-19       Impact factor: 4.307

9.  Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.

Authors:  Taraneh Rajaei; Hamid Farajifard; Seyed Abdolrahim Rezaee; Mahmoud Reza Azarpazhooh; Mahmoud Mahmoudi; Narges Valizadeh; Houshang Rafatpanah
Journal:  Med Microbiol Immunol       Date:  2018-10-20       Impact factor: 3.402

10.  Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis.

Authors:  Taekyun Shin; Meejung Ahn; Changjong Moon; Seungjoon Kim
Journal:  Anat Cell Biol       Date:  2012-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.